Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Non-cash Items (2019)

Madrigal Pharmaceuticals (MDGL) has disclosed Non-cash Items for 5 consecutive years, with $673303.0 as the latest value for Q1 2019.

  • On a quarterly basis, Non-cash Items changed N/A to $673303.0 in Q1 2019 year-over-year; TTM through Mar 2019 was $673303.0, a N/A change, with the full-year FY2014 number at $4.9 million, up 26.52% from a year prior.
  • Non-cash Items was $673303.0 for Q1 2019 at Madrigal Pharmaceuticals, down from $5.5 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $5.6 million in Q2 2015 to a low of $673303.0 in Q1 2019.